Record NNP B-NP O
date NN I-NP O
: : O O
2093-11-30 CD O B-DATE
LOVELAND NNP B-NP B-HOSPITAL
MEMEORIAL NNP I-NP I-HOSPITAL
HOSPITAL NNP I-NP I-HOSPITAL
LOVELAND NNP B-NP B-HOSPITAL
Internal NNP I-NP O
Medicine NNP I-NP O
Associates NNPS I-NP O
23 CD B-NP B-STREET
Colgate NNP I-NP I-STREET
Road NNP I-NP I-STREET
Youngman NNP I-NP I-PATIENT
, , O I-PATIENT
Cody NNP B-NP I-PATIENT
Cincinnati NNP B-NP B-CITY
, , O O
WA VBD B-VP B-STATE
33699 CD B-NP B-ZIP
06386371 CD I-NP B-MEDICALRECORD
11-30-93 CD O B-DATE
IDENTIFICATION NN B-NP O
: : O O
Ms. NNP B-NP O
Youngman NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
36 CD I-NP B-AGE
year NN I-NP O
old JJ I-NP O
woman NN I-NP O
with IN B-PP O
the DT B-NP O
following VBG I-NP O
medical JJ B-NP O
problems NNS I-NP O
: : O O
1 CD B-NP O
. . O O
Type NNP B-NP O
II NNP I-NP O
diabetes NN I-NP O
mellitus NN I-NP O
. . O O
2. . B-NP O
CAD. NNP I-NP O
3. DT B-NP O
History NN I-NP O
of IN B-PP O
CIN2 DT B-NP O
status NN I-NP O
post NN I-NP O
laser NN I-NP O
treatment NN I-NP O
to TO B-PP O
the DT B-NP O
cervix NN I-NP O
. . O O
4 LS O O
. . B-NP O
Depression NNP I-NP O
. . O O
5 CD B-LST O
. . O O
History NN B-NP O
of IN B-PP O
substance NN B-NP O
abuse NN I-NP O
. . O O
6 CD B-LST O
. . O O
GERD. '' O O
CURRENT JJ B-NP O
MEDICATIONS NNS I-NP O
: : O O
Enteric-coated JJ B-NP O
aspirin NN I-NP O
325mg JJ B-NP O
PO NNP I-NP O
q.d. NNP I-NP O
, , O O
atenolol NN B-NP O
25mg JJ B-NP O
PO NNP I-NP O
q.d. NNP I-NP O
, , O O
glyburide NN B-NP O
5mg IN B-PP O
PO NNP B-NP O
q.d. NNP I-NP O
, , O O
Lipitor NNP B-NP O
10mg CD I-NP O
PO NNP I-NP O
q.h NNP I-NP O
.s. NNP I-NP O
, , O O
Celexa NNP B-NP O
20mg CD I-NP O
PO NNP B-NP O
q.d. NNP I-NP O
, , O O
Zantac NNP B-NP O
150mg CD I-NP O
PO NNP I-NP O
q.h NNP I-NP O
.s. NNP I-NP O
, , O O
Prevacid NNP B-NP O
30mg CD I-NP O
PO NNP I-NP O
q.d. NNP I-NP O
, , O O
trazodone NN B-NP O
150mg CD I-NP O
PO NNP B-NP O
q.h NN I-NP O
.s NNS I-NP O
. . O O
HISTORY NN B-NP O
OF IN B-PP O
PRESENT JJ B-NP O
ILLNESS NNS I-NP O
: : O O
Ms. NNP B-NP O
Youngman NNP I-NP B-PATIENT
returns VBZ B-VP O
to TO B-PP O
clinic NN B-NP O
today NN I-NP O
to TO O O
follow VB B-VP O
up RP B-NP O
regarding VBG B-VP O
her PRP B-NP O
diabetes NN B-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
and CC O O
depression NN B-NP O
. . B-VP O
Since IN B-SBAR O
I PRP B-NP O
last RB B-ADVP O
saw VBD B-VP O
her PRP B-NP O
, , O O
she PRP B-NP O
presented VBD B-VP O
to TO B-PP O
Urgent NNP B-NP O
Care NNP I-NP O
complaining VBG B-VP O
of IN B-PP O
some DT B-NP O
epigastric JJ I-NP O
discomfort NN I-NP O
and CC O O
was VBD B-VP O
referred VBN I-VP O
to TO I-VP O
Gastroenterology NN B-NP O
where WRB B-ADVP O
apparently RB B-ADVP O
she PRP B-NP O
was VBD B-VP O
started VBN I-VP O
on IN B-PP O
Prevacid NNP B-NP O
at IN B-PP O
30mg CD B-NP O
a DT O O
day NN B-NP O
in IN B-PP O
addition NN B-NP O
to TO B-PP O
maintenance NN B-NP O
with IN B-PP O
q.h JJ B-NP O
.s NNS I-NP O
. . O O
Zantac NNP B-NP O
and CC O O
scheduled VBN B-VP O
for IN B-PP O
a DT B-NP O
upper JJ B-NP O
GI JJ I-NP O
series NN I-NP O
with IN B-PP O
a DT B-NP O
small JJ I-NP O
bowel NN I-NP O
follow-through JJ B-ADJP O
with IN B-PP O
a DT B-NP O
plan NN I-NP O
to TO B-VP O
add VB I-VP O
a DT O O
pro-motility JJ B-NP O
agent NN I-NP O
if IN B-SBAR O
there EX B-NP O
was VBD B-VP O
no DT B-NP O
structural JJ I-NP O
abnormalities NNS I-NP O
on IN B-PP O
her PRP B-NP O
GI . O O
study NN B-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
scheduled VBN I-VP O
later RB B-NP O
this DT I-NP O
month NN I-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
no DT B-NP O
new JJ I-NP O
complaints NNS I-NP O
, , O O
although IN B-SBAR O
she PRP B-NP O
recently RB B-ADVP O
stopped VBD B-VP O
taking VBG I-VP O
her PRP$ B-NP O
glyburide NN I-NP O
and CC O O
has VBZ B-VP O
not RB I-VP O
refilled VBN I-VP O
it PRP B-NP O
over IN B-PP O
the DT B-NP O
past JJ I-NP O
two CD I-NP O
days NNS I-NP O
. . O O
She PRP B-NP O
denies VBZ B-VP O
any DT B-NP O
increasing VBG I-NP O
polyuria NN I-NP O
, , O O
polydipsia NN B-NP O
, , O O
polyphagia NN B-NP O
. . O O
Says VBZ B-VP O
until IN B-PP O
yesterday NN B-NP O
, , O O
she PRP B-NP O
had VBD B-VP O
been VBN I-VP O
taking VBG I-VP O
all PDT O O
of IN B-PP O
her PRP$ B-NP O
medications NNS I-NP O
regularly RB B-ADVP O
, , O O
although IN B-SBAR O
mostly RB B-ADVP O
at IN B-PP O
night NN B-NP O
rather RB B-PP O
than IN I-PP O
in IN B-PP O
the DT B-NP O
morning NN I-NP O
. . O O
I PRP B-NP O
pressed VBD B-VP O
her PRP B-NP O
about IN B-PP O
this DT B-NP O
because IN B-SBAR O
she PRP B-NP O
has VBZ B-VP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
being VBG B-VP O
noncompliant JJ B-ADJP O
with IN B-PP O
her PRP$ B-NP O
medicines NNS I-NP O
in IN B-PP O
the DT B-NP O
past NN I-NP O
, , O O
but CC O O
she PRP B-NP O
does VBZ B-VP O
maintain VB I-VP O
that IN B-SBAR O
she PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
taking VBG I-VP O
them PRP B-NP O
. . O O
It PRP B-NP O
is VBZ B-VP O
not RB O O
entirely RB B-ADJP O
clear JJ I-ADJP O
to TO B-PP O
me PRP B-NP O
whether IN O O
this DT B-NP O
is VBZ B-VP O
true JJ B-ADJP O
or CC O O
not RB B-ADJP O
. . O O
Regarding VBG B-VP O
her PRP$ B-NP O
depression NN I-NP O
, , O O
she PRP B-NP O
denies VBZ B-VP O
any DT B-NP O
suicidal NN I-NP O
ideation NN I-NP O
. . O O
She PRP B-NP O
says VBZ B-LST O
she PRP B-NP O
is VBZ B-VP O
feeling VBG I-VP O
a DT B-NP O
little JJ I-NP O
bit NN I-NP O
better RB B-ADVP O
. . O O
She PRP B-NP O
was VBD B-VP O
recently RB I-VP O
started VBN I-VP O
on IN B-PP O
risperidone VBN B-VP O
in IN B-PP O
addition NN B-NP O
to TO B-PP O
her PRP$ B-NP O
Celexa NNP I-NP O
, , O O
apparently RB B-ADVP O
by IN B-PP O
a DT B-NP O
psychiatrist NN I-NP O
at IN B-PP O
the DT B-NP O
Connerstone NNP I-NP B-HOSPITAL
Regional NNP I-NP I-HOSPITAL
Hospital NNP I-NP I-HOSPITAL
by IN B-PP O
the DT B-NP O
name NN I-NP O
of IN B-PP O
Dr. NNP B-NP O
Lehman NNP I-NP B-DOCTOR
whom WP B-NP O
she PRP B-NP O
sees VBZ B-VP O
once RB O O
a DT B-NP O
month NN I-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
also RB I-VP O
seeing VBG I-VP O
a DT B-NP O
counselor NN I-NP O
there RB B-ADVP O
weekly RB I-ADVP O
. . O O
She PRP B-NP O
says VBZ B-VP O
overall JJ O O
she PRP B-NP O
is VBZ B-VP O
doing VBG I-VP O
a DT B-NP O
little JJ I-NP O
bit NN I-NP O
better JJR I-NP O
, , O O
although IN B-SBAR O
still RB B-ADVP O
intermittently RB B-NP O
binge NN I-NP O
drinking NN B-NP O
and CC O O
occasionally RB B-VP O
smoking VBG I-VP O
marijuana NN B-NP O
. . O O
We PRP B-NP O
again RB B-ADVP O
discussed VBD B-VP O
the DT O O
importance NN B-NP O
of IN B-PP O
AA NNP B-NP O
; : O O
she PRP B-NP O
says VBZ B-VP O
she PRP B-NP O
is VBZ B-VP O
not RB O O
interested JJ B-ADJP O
in IN B-PP O
that DT B-NP O
. . O O
Regarding VBG B-VP O
her PRP$ B-NP O
coronary JJ I-NP O
disease NN I-NP O
, , O O
she PRP B-NP O
continues VBZ B-VP O
to TO I-VP O
have VB I-VP O
exertional JJ B-NP O
angina NN I-NP O
after IN B-SBAR O
approximately RB B-NP O
14 CD I-NP O
steps NNS I-NP O
which WDT B-NP O
has VBZ B-VP O
not RB I-VP O
increased VBN I-VP O
in IN B-PP O
intensity NN B-NP O
or CC O O
frequency NN B-NP O
. . O O
She PRP B-NP O
denies VBZ B-VP O
any DT B-NP O
PND NN I-NP O
or CC I-NP O
orthopnea NN I-NP O
, , O O
denies VBZ B-VP O
any DT B-NP O
chest NN I-NP O
pain NN I-NP O
at IN B-PP O
rest NN B-NP O
. . O O
LOVELAND NNP B-NP B-HOSPITAL
MEMEORIAL NNP I-NP I-HOSPITAL
HOSPITAL NNP I-NP I-HOSPITAL
LOVELAND NNP B-NP B-HOSPITAL
Internal NNP I-NP O
Medicine NNP I-NP O
Associates NNPS I-NP O
57 CD B-NP B-STREET
Colgate NNP I-NP I-STREET
Road NNP I-NP I-STREET
Youngman NNP I-NP I-PATIENT
, , O I-PATIENT
Cody NNP B-NP I-PATIENT
Cincinnati NNP B-NP B-CITY
, , O O
WA VBD B-VP B-STATE
33699 CD B-NP B-ZIP
06386371 CD I-NP B-MEDICALRECORD
11-30-93 CD O B-DATE
Page NNP B-NP O
2 CD I-NP O
PHYSICAL NNP B-NP O
EXAM NNP I-NP O
: : O O
She PRP B-NP O
is VBZ B-VP O
a DT B-NP O
morbidly RB I-NP O
obese JJ I-NP O
woman NN I-NP O
in IN B-PP O
no DT B-NP O
acute JJ I-NP O
distress NN I-NP O
. . O O
Her PRP$ O O
pulse NN B-NP O
is VBZ B-VP O
80 CD B-NP O
and CC I-NP O
regular JJ I-NP O
, , O O
blood NN B-NP O
pressure NN I-NP O
134/74 CD B-NP O
. . O O
Her PRP$ B-NP O
weight NN I-NP O
today NN I-NP O
is VBZ O O
249lb JJ B-ADJP O
. . O O
Her PRP$ B-NP O
sclera NN I-NP O
are VBP B-VP O
nonicteric JJ B-ADJP O
. . O O
Her PRP$ B-NP O
JVP NNP I-NP O
is VBZ B-VP O
not RB O O
visible JJ B-ADJP O
at IN B-SBAR O
90 CD B-UCP O
degrees NNS B-NP O
. . O O
There EX B-NP O
are VBP B-VP O
no DT B-NP O
carotid NN I-NP O
bruits NNS I-NP O
. . O O
Her PRP$ B-NP O
lungs NNS I-NP O
are VBP B-VP O
clear JJ B-ADJP O
to TO O O
auscultation NN B-NP O
bilaterally RB I-NP O
, , O O
and CC O O
her PRP$ B-NP O
cardiac NN I-NP O
exam NN I-NP O
reveals VBZ B-VP O
a DT B-NP O
regular JJ I-NP O
rhythm NN I-NP O
, , O O
positive JJ B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
. . O O
No DT B-NP O
murmurs NNS I-NP O
, , O O
rubs NNS B-NP O
, , O O
or CC O O
gallops NNS B-NP O
appreciated VBN B-VP O
. . O O
Her PRP$ O O
extremities NNS B-NP O
are VBP B-VP O
warm JJ B-ADJP O
and CC O O
without IN B-SBAR O
significant JJ B-NP O
edema NN I-NP O
. . O O
Her PRP$ B-NP O
finger NN I-NP O
stick VB B-LST O
blood NN B-NP O
sugar NN I-NP O
in IN B-PP O
the DT B-NP O
office NN I-NP O
today NN I-NP O
was VBD B-VP O
331 CD B-NP O
. . O O
ASSESSMENT/PLAN NNP B-NP O
: : O O
Thirty CD B-NP B-AGE
six CD I-NP I-AGE
year NN I-NP O
old JJ I-NP O
woman NN I-NP O
with IN B-PP O
multiple JJ B-NP O
medical JJ I-NP O
problems NNS B-NP O
, , O O
including VBG B-PP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
noncompliance NN B-NP O
and CC I-NP O
substance NN I-NP O
abuse NN I-NP O
. . O O
1 LS O O
. . B-NP O
Diabetes NNP I-NP O
. . O O
Her PRP$ B-NP O
last JJ I-NP O
hemoglobin NN I-NP O
A1C NNP I-NP O
was VBD B-VP O
approximately RB B-NP O
9.3 CD I-NP O
, , O O
essentially RB B-ADJP O
unchanged JJ I-ADJP O
from IN B-PP O
six CD B-NP O
months NNS I-NP O
prior RB B-ADVP O
. . O O
Finger NNP B-NP O
stick NN I-NP O
in IN B-PP O
the DT O O
office NN B-NP O
is VBZ B-VP O
331 CD B-NP O
today NN I-NP O
, , O O
confirming VBG B-VP O
her PRP$ B-NP O
recent JJ I-NP O
noncompliance NN I-NP O
and CC O O
would MD O O
now RB B-ADVP O
describe VBP B-VP O
that IN B-SBAR O
she PRP B-NP O
has VBZ B-VP O
not RB I-VP O
been VBN I-VP O
taking VBG I-VP O
her PRP$ B-NP O
medicine NN I-NP O
regularly RB O O
over IN B-PP O
the DT B-NP O
past JJ I-NP O
couple NN I-NP O
of IN B-PP O
months NNS B-NP O
. . B-NP O
In IN B-PP O
any DT B-NP O
event NN I-NP O
, , O O
she PRP B-NP O
most RBS B-NP O
likely JJ I-NP O
need NN I-NP O
a DT B-NP O
higher JJR I-NP O
dose NN I-NP O
of IN B-PP O
sulphonurea NN B-NP O
. . O O
We PRP B-NP O
will MD B-VP O
check VB I-VP O
a DT B-NP O
hemoglobin NN I-NP O
A1C . O O
today NN B-NP O
, , O O
and CC O O
if IN B-SBAR O
it PRP B-NP O
remains VBZ B-VP O
in IN B-PP O
the DT B-NP O
9 CD I-NP O
range NN I-NP O
or CC O O
higher JJR B-NP O
, , O O
will MD B-VP O
increase VB I-VP O
her PRP$ B-NP O
glyburide NN I-NP O
to TO B-PP O
10mg CD B-NP O
daily JJ I-NP O
, , O O
and CC O O
I PRP B-NP O
talked VBD B-VP O
to TO B-PP O
her PRP B-NP O
about IN B-PP O
the DT B-NP O
plan NN I-NP O
. . O O
Her PRP$ B-NP O
last JJ I-NP O
urine NN I-NP O
microalbumin NN I-NP O
was VBD B-VP O
negative JJ B-ADJP O
. . O O
2. DT B-NP O
Hypercholesterolemia NNP I-NP O
. . O O
When WRB B-ADVP O
she PRP B-NP O
returns VBZ B-VP O
to TO B-PP O
clinic NN B-NP O
in IN B-PP O
three CD B-NP O
months NNS I-NP O
, , O O
we PRP B-NP O
will MD B-VP O
recheck VB I-VP O
a DT B-NP O
lipid JJ I-NP O
profile NN I-NP O
by IN B-PP O
which WDT B-NP O
time NN B-NP O
she PRP B-NP O
will MD B-VP O
have VB I-VP O
been VBN I-VP O
on IN B-PP O
Lipitor NNP B-NP O
for IN B-PP O
approximately RB B-NP O
six CD I-NP O
months NNS I-NP O
. . O O
3. DT B-NP O
Coronary JJ I-NP O
disease NN I-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
still RB I-VP O
having VBG I-VP O
exertional JJ B-NP O
chest NN I-NP O
pain NN I-NP O
. . O O
Increased VBN B-VP O
her PRP$ B-NP O
atenolol NN I-NP O
to TO B-PP O
50mg CD B-NP O
PO NN I-NP O
q.d NN I-NP O
. . O O
as IN B-SBAR O
she PRP B-NP O
did VBD B-VP O
have VB I-VP O
room NN B-NP O
to TO B-VP O
go VB I-VP O
with IN B-PP O
her PRP$ B-NP O
pulse NN I-NP O
and CC I-NP O
blood NN I-NP O
pressure NN I-NP O
. . O O
4 LS O O
. . B-NP O
Depression NNP I-NP O
. . O O
I PRP B-NP O
again RB B-ADVP O
encouraged VBD B-VP O
her PRP$ B-NP O
to TO B-VP O
continue VB I-VP O
following VBG I-VP O
up RP B-PRT O
with IN O O
her PRP$ B-NP O
psychiatrist NN I-NP O
and CC O O
her PRP$ B-NP O
counselor NN I-NP O
. . O O
Again RB B-ADVP O
, , O O
reinforced VBD B-VP O
the DT O O
importance NN B-NP O
of IN B-PP O
trying VBG B-VP O
to TO I-VP O
remain VB I-VP O
substance NN B-NP O
free JJ I-NP O
and CC O O
recommended VBD B-VP O
AA NNP B-NP O
again RB B-ADVP O
as IN B-SBAR O
I PRP B-NP O
have VBP B-VP O
in IN B-PP O
the DT B-NP O
past NN I-NP O
. . O O
5 CD B-NP O
. . O O
GERD. NNP O O
She PRP B-NP O
will MD B-VP O
follow VB I-VP O
up RP B-PRT O
with IN B-NP O
Gastroenterology NNP I-NP O
and CC O O
continue VB B-VP O
on IN B-PP O
her PRP$ B-NP O
PPI NNP B-NP O
and CC I-NP O
H2 NNP I-NP O
blocker NN I-NP O
for IN B-PP O
now RB B-NP O
. . O O
I PRP B-NP O
told VBD B-VP O
her PRP B-NP O
she PRP B-NP O
should MD B-VP O
take VB I-VP O
the DT B-NP O
Prevacid NNP B-NP O
in IN B-PP O
the DT B-NP O
morning NN I-NP O
and CC O O
the DT B-NP O
Zantac NNP I-NP O
at IN B-PP O
night NN B-NP O
only RB B-ADVP O
. . O O
6 CD B-NP O
. . O O
Health NNP B-NP O
maintenance NN I-NP O
. . O O
She PRP B-NP O
received VBD B-VP O
a DT B-NP O
flu NN I-NP O
shot NN I-NP O
and CC O O
she PRP B-NP O
will MD B-VP O
return VB I-VP O
to TO I-VP O
clinic NN B-NP O
in IN B-PP O
three CD B-NP O
months NNS I-NP O
to TO B-VP O
follow VB I-VP O
up RP B-PRT O
on IN B-PP O
her PRP$ B-NP O
diabetes NN I-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
and CC O O
coronary JJ B-NP O
disease NN I-NP O
. . O O
Additionally RB B-ADVP O
, , O O
I PRP B-NP O
referred VBD B-VP O
her PRP$ B-NP O
to TO B-PP O
Nutrition NNP B-NP O
for IN B-PP O
further JJ B-NP O
counseling NN I-NP O
regarding VBG I-NP O
weight NN I-NP O
loss NN B-NP O
and CC O O
a DT B-NP O
heart-healthy JJ I-NP O
diabetic NN I-NP O
diet NN I-NP O
. . O O
I PRP B-NP O
also RB B-ADVP O
stressed VBD B-VP O
the DT O O
LOVELAND NNP B-NP B-HOSPITAL
MEMEORIAL NNP I-NP I-HOSPITAL
HOSPITAL NNP I-NP I-HOSPITAL
LOVELAND NNP B-NP B-HOSPITAL
Internal NNP I-NP O
Medicine NNP I-NP O
Associates NNPS I-NP O
06 CD B-NP B-STREET
Colgate NNP I-NP I-STREET
Road NNP I-NP I-STREET
Youngman NNP I-NP I-PATIENT
, , O I-PATIENT
Cody NNP B-NP I-PATIENT
Cincinnati NNP B-NP B-CITY
, , O O
WA VBD B-VP B-STATE
33699 CD B-NP B-ZIP
06386371 CD I-NP B-MEDICALRECORD
11-30-93 CD O B-DATE
Page NNP B-NP O
3 CD I-NP O
importance NN B-NP O
of IN B-PP O
her PRP$ B-NP O
seeing VBG B-VP O
the DT B-NP O
eye NN I-NP O
doctor NN I-NP O
. . O O
She PRP B-NP O
says VBZ B-VP O
she PRP B-NP O
is VBZ B-VP O
scheduled VBN I-VP O
to TO B-VP O
see VB I-VP O
the DT B-NP O
eye NN I-NP O
doctor NN I-NP O
this DT B-NP O
month NN I-NP O
given VBN B-VP O
that IN B-SBAR O
she PRP B-NP O
is VBZ B-VP O
at IN B-PP O
risk NN B-NP O
for IN B-PP O
diabetic JJ B-NP O
retinopathy NN I-NP O
. . O O
Jeffrey NNP B-NP B-DOCTOR
Koehler NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
LX NNP B-NP I-IDNUM
:ZK:3809 CD I-NP I-IDNUM
; : O O
DD NNP B-NP O
: : O O
11-30-93 CD B-NP B-DATE
; : O O
DT NNP B-NP O
: : O O
12-3-93 CD B-NP B-DATE
; : O O
DV NNP B-NP O
: : O O
11-30-93 CD O B-DATE
== NN B-NP O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
Preceptor NNP B-NP O
's POS B-NP O
Note NNP I-NP O
== NNP I-NP O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
Case NNP B-NP O
discussed VBD B-VP O
with IN B-PP O
Dr NNP B-NP O
Koehler NNP I-NP B-DOCTOR
. . I-NP O
DM NNP I-NP O
: : O O
glucose NN B-NP O
in IN B-PP O
the DT B-NP O
300s CD I-NP O
. . O O
Ran VBD B-VP O
out IN B-PP O
of IN B-PP O
meds NNS B-NP O
. . O O
Compliance NN B-VP O
a DT B-NP O
problem NN I-NP O
. . O O
We PRP B-NP O
are VBP B-VP O
restarting VBG I-VP O
glyburide NN B-NP O
today NN I-NP O
. . O O
MIBI NN B-NP O
was VBD B-VP O
positive JJ B-ADJP O
, , O O
but CC O O
we PRP B-NP O
are VBP B-VP O
trying VBG I-VP O
medical JJ B-NP O
management NN I-NP O
. . O O
Increasing VBG B-VP O
atenolol NN B-NP O
to TO B-PP O
50mg CD B-NP O
. . O O
Cont NNP O O
. . O O
Lipitor NNP O O
for IN B-PP O
lipids NNS B-NP O
. . O O
close NN B-VP O
f/u RB I-VP O
planned VBN I-VP O
. . O O
